Neuphoria Therapeutics Statistics
Total Valuation
NEUP has a market cap or net worth of $22.37 million. The enterprise value is $235,265.
Important Dates
The last earnings date was Tuesday, February 17, 2026, after market close.
| Earnings Date | Feb 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NEUP has 5.39 million shares outstanding. The number of shares has increased by 123.33% in one year.
| Current Share Class | 5.39M |
| Shares Outstanding | 5.39M |
| Shares Change (YoY) | +123.33% |
| Shares Change (QoQ) | +101.96% |
| Owned by Insiders (%) | 3.41% |
| Owned by Institutions (%) | 31.32% |
| Float | 4.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.49 |
| Forward PS | n/a |
| PB Ratio | 0.75 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.04 |
| Quick Ratio | 8.76 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.07% and return on invested capital (ROIC) is -56.94%.
| Return on Equity (ROE) | -26.07% |
| Return on Assets (ROA) | -4.25% |
| Return on Invested Capital (ROIC) | -56.94% |
| Return on Capital Employed (ROCE) | -5.48% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $1.87M |
| Profits Per Employee | -$707,989 |
| Employee Count | 8 |
| Asset Turnover | 0.55 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -417,375 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -19.26% |
| 50-Day Moving Average | 4.04 |
| 200-Day Moving Average | 7.10 |
| Relative Strength Index (RSI) | 48.41 |
| Average Volume (20 Days) | 25,251 |
Short Selling Information
The latest short interest is 36,994, so 0.69% of the outstanding shares have been sold short.
| Short Interest | 36,994 |
| Short Previous Month | 40,719 |
| Short % of Shares Out | 0.69% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 0.75 |
Income Statement
In the last 12 months, NEUP had revenue of $14.99 million and -$5.66 million in losses. Loss per share was -$2.18.
| Revenue | 14.99M |
| Gross Profit | 14.99M |
| Operating Income | -1.86M |
| Pretax Income | -6.08M |
| Net Income | -5.66M |
| EBITDA | -1.20M |
| EBIT | -1.86M |
| Loss Per Share | -$2.18 |
Full Income StatementBalance Sheet
The company has $22.17 million in cash and $33,465 in debt, with a net cash position of $22.14 million or $4.11 per share.
| Cash & Cash Equivalents | 22.17M |
| Total Debt | 33,465 |
| Net Cash | 22.14M |
| Net Cash Per Share | $4.11 |
| Equity (Book Value) | 29.70M |
| Book Value Per Share | 5.52 |
| Working Capital | 20.80M |
Full Balance SheetCash Flow
| Operating Cash Flow | -2.36M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.36M |
| FCF Per Share | -$0.44 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -12.43% and -37.79%.
| Gross Margin | 100.00% |
| Operating Margin | -12.43% |
| Pretax Margin | -40.58% |
| Profit Margin | -37.79% |
| EBITDA Margin | -8.01% |
| EBIT Margin | -12.43% |
| FCF Margin | n/a |
Dividends & Yields
NEUP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -123.33% |
| Shareholder Yield | -123.33% |
| Earnings Yield | -25.32% |
| FCF Yield | -10.56% |
Analyst Forecast
The average price target for NEUP is $21.00, which is 406.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 406.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 31.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NEUP has an Altman Z-Score of -4.91 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.91 |
| Piotroski F-Score | 3 |
